Key Financial Data Of Group

Cyfuse Biomedical K.K. - Filing #7372948

Concept As at
2023-09-30
2023-01-01 to
2023-09-30
2023-07-01 to
2023-09-30
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-09-30
As at
2022-09-30
2022-07-01 to
2022-09-30
Key financial data of group
Business results of group
Net sales
29,729,000 JPY
374,477,000 JPY
340,755,000 JPY
Ordinary profit (loss)
-532,243,000 JPY
-433,165,000 JPY
-232,579,000 JPY
Net assets
3,241,159,000 JPY
3,769,801,000 JPY
1,761,553,000 JPY
Total assets
4,172,122,000 JPY
4,815,337,000 JPY
2,720,093,000 JPY
Basic earnings (loss) per share
-68.47
-21.74
-177.67
-193.26
-51.12
Diluted earnings per share
Equity-to-asset ratio
0.777 xbrli:pure
0.783 xbrli:pure
0.647 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.